This page describes pharmacological agents that may have legal restrictions, side effects, and drug interactions in your jurisdiction. Information is for educational research only — consult a clinician before considering any compound.

High-risk compound

Surface here is educational only; do not use without medical supervision. Our editorial verdict is SKIP-FOR-NOW — current cost / risk / redundancy puts it below the line.

Browse

Actovegin

Deproteinized calf-blood hemodialysate.

Aliases (4)
deproteinized calf blood hemodialysate · DCBH · Solcoseryl-like · Nycomed Actovegin
TYPICAL DOSE
ROUTE
CYCLE
STORAGE

Overview

What is Actovegin?

Deproteinized calf-blood hemodialysate. EU + Russian sports-medicine recovery tool, especially in elite football for hamstring/muscle injuries. Cochrane reviews say "insufficient evidence" for the other claimed indications. Not a fit without a specific injury context.

What to Expect

  • Week 1
    Tolerability and dose-response.
  • Week 2-4
    Early effect window.
  • Week 4-8
    Peak benefit assessment.
  • Week 8+
    Cycle decision point.
Was this helpful?
Your feedback shapes what we research deeper.

How was your experience with this compound?

Anonymous · one vote per session · results below at 5+ votes.

Loading…

See something off?

Most of this wiki is AI-generated. Suggest a correction, dosing update, or new evidence — we review every submission.

Discussion — click to load
Loading…
Continue: Extended research →
Our verdict, decision matrix, deep dives, controversies, sources